2024 Digital Insights: Pfizer’s Nurtec and AstraZeneca’s Breztri Shine
Investors Hangout
Trinity Life Sciences’ fourth annual TGaS Digital Marketing Competency Report was featured in an article published on Investors Hangout. Read Now…
How to achieve a successful drug launch in the first year
MM+M
Trinity’s Krista Perry, Partner & Head of Launch Excellence, was featured in an article by MM+M titled, “How to achieve a successful drug launch.” Read the article to learn more about what factors contribute to a successful drug launch. Read Now…
The Challenges and Opportunities in Clinical Trial Diversity: Mistrust in the healthcare system is a significant barrier to recruitment
Drug Discovery Today
Trinity’s Lisa Bailey, Ph.D., Managing Director of Insights & Head of DEI Strategy, authored an article that was published in Drug Discovery Today. Read the article, “The Challenges and Opportunities in Clinical Trial Diversity: Mistrust in the healthcare system is a significant barrier to recruitment,” to learn more. Read Now…
Drugs for unmet needs and those from experienced companies had the best chance for successful launches in 2023: report
Fierce Pharma
Trinity’s Krista Perry, Partner & Head of Launch Excellence, was featured in an article by Fierce Pharma to discuss our latest white paper, Moving the Needle: Lessons from the 2023 Launch Class. Read the article to learn more about what factors contribute to a successful drug launch. Read Now…
Half of US meds launched in 2023 ‘underperformed’
The Pharma Letter
Trinity Life Sciences’ recent white paper on the first year performance of the 2023 launch class was featured in an article published on The Pharma Letter. Read Now…
Precision, planning and creativity for launch excellence in a volatile sector
Pharmaceutical Market Europe
Trinity’s recent white paper, Picking Winners: Portfolio Management for a New Era, was mentioned in a recent article by Pharmaceutical Market Europe. Read Now…
How biopharma companies can make the best choices
The Pharma Letter
The biopharma industry is intensely competitive, and companies must go to great lengths to gain any commercial edge. However, it is also an industry that sees more failure than success. Leslie Orne, President & CEO of Trinity Life Sciences, provides an expert view in The Pharma Letter on how biopharma companies can make the best choices to achieve commercial success. Read Now…
Big savings? Analyzing the IRA’s impact on the industry
MM+M Podcast
Trinity Life Science’s Monica Martin De Bustamante analyzes the Medicare-negotiated prices of the first 10 drugs under the Inflation Reduction Act. Listen Now…
People on the Move in Boston: Nancy Phelan
Boston Business Journal
Check out Nancy Phelan’s profile in the Boston Business Journal. Read Now…
Finding the Trust in Clinical Trials: Q&A with Lisa Bailey
Pharmaceutical Executive
It’s clear that there is still work to be done with regard to diversity in clinical trials. Lisa Bailey, Managing Director and Head of DEI Strategy at Trinity Life Sciences, shares her insights with Pharmaceutical Executive on the lack of diversity in trials and how the industry can work to solve this problem. Read Now…